2m 2m 2m 2m 2m 2m 2m
LARIMAR THERAP (LRMR)
NASDAQ
$2.30-$0.12 (-4.96%)
Price as of Oct 22, 2026 7:45 PM EDT- $251.4MMarket Cap
- -38.42%1-Year Change
- BiotechnologyIndustry
LARIMAR THERAP (LRMR)
$2.30-$0.12 (-4.96%)
LRMR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.42 | ||
Change | -$0.02 (-0.82%) | ||
Open | $2.40 | ||
High | $2.54 | ||
Low | $2.39 | ||
Previous Close | $2.44 | ||
Volume | 1,512,896 | ||
30-Day Average Volume | 1,707,814 | ||
1-Week Change | 15.79% | ||
1-Month Change | -36.81% | ||
1-Year Change | -38.42% | ||
3-Year Change | -17.12% | ||
5-Year Change | -80.64% | ||
Fundamentals | |||
Shares Outstanding | 103.9M | ||
Total Assets | $165.3M | ||
Market Cap | $251.4M | ||
Enterprise Value | $158.7M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$32.8M | ||
Free Cash Flow | -$44.1M | ||
EBIT | -$32.8M | ||
EBITDA | -$32.7M | ||
Net Working Capital | $126.5M | ||
EPS | $0.30 | ||
Enterprise Value/EBITDA | -5 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | 8 | ||
PEG | 0 | ||
Price/Free Cash Flow | -6 | ||
Price/Operating Cash Flow | -6 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue